What is Ginkgo Bioworks and why watch out for it?



In May of this year, a company with such a name appeared on the public market and its value is estimated at 15 billion dollars. What is it about the company and why should you be careful about it?

It's the new rising biotechnology star of the Reset Agenda planners, so to speak. It is not yet as well known as Monsanto, which is rightly called the worst company in the world, but its profile and research show that it can even beat it.

They call themselves exactly that - a company of organisms. It was founded in 2009 and again they are scientists of MIT or Massachusetts State Institute of Technology. It's biological engineering, and that's what the company's motto sounds like - we create, develop, test, produce and license organisms. Their work is called 'design biology' and it means programming cells to produce everything they can, from food to a variety of materials and therapies. It is the programming of genes to create new DNA and new organisms, which are then resold under license and used in a variety of industries, from artificial sweeteners to medicine.

As long as they are not so well known in the world, they do not lack money. In 2015, they raised 9 million dollars in the first investor attraction event. A few months later received 45 million from Viking Global Investors. But already 3 years ago, the company was already worth a billion, including 429 million invested there by Cascade Investment. More interestingly, last November, Ginko received a $ 1.1 billion loan from the U.S. government to test hard and develop raw materials for future pandemics.

The Ginkgo consortium, on the other hand, continues to build its own companies, one of which is Allonia, which launched $ 40 million worth of wastewater research in October 2020 to look for cools there. This is all in line with the WHO’s Global Environmental Monitoring Program, which is part of the ‘fight’ plan plan.

In fact, it is part of Reset, where the goals of overcoming global crises and transforming existing industries are sufficiently clearly defined. That is all that the Davos junta and the regimes that serve it want to do.

And again here you see all the same spider web. Cascade Investment is a Bill Gates-controlled company and has become the largest landowner in the United States.

But Ginkgo Bioworks is clearly identified as a partner in the Davos Forum, and so is its leader, Jason Kelly. Ryan Morhard, who is responsible for the company's public relations, is also the author of the Davos Forum. He worked there before joining Ginko and was once responsible for global risk and health security research. It looks like another reset brigade in practice. Already in 2016, the Davos Forum recognized this company as one of the most innovative in the world.

And that's why it's on the list of Davos partners who will be responsible for shaping the future for Reset. It's a whole fantasy package, as Schwab sees a post-pandemic world that is technocratic, digital and a nightmare of transhumanism when viewed by a normal person. But tools have been chosen for this nightmare, they are crammed with money and this company is one of the weapons against humanity, so it would be worth at least knowing about it. It's really like a spider weaving its net - several companies like Joyn Bio and MotifFoodWorks have been spun off from it in recent years - to understand what that means - Joyn Bio has partnered with Bayer Crop Sciences for $ 100 million, while Motif is a $ 90 million partnership with Fonterra and Loius Dreyfus. And they are global agricultural and financial corporations.

And then what is Joyn Bio going to do? They will produce microbes in agriculture, but MotifFoodWorks is working on a strategy where people will be offered genetically modified plants - so it's all in Reset's ideology, where food no longer grows in nature but in laboratories. Another branch of Ginko Coincentric is engaged in the production of kovid tests specifically for children in schools. The same network can be found here as well, as the company's vice president Dylan George has previously worked on both US government biosecurity projects and the CIA investment company, which has links to Facebook funding, as well as the biomedical military complex BARDA. Coincentric shots contain many of these interesting types, including U.S. Army soldiers and former DARPA associates.

In short, everything is intertwined here - the US military, DARPA, the CIA, the Davos Forum and what not. So what future do they plan for us? Ginkgo answers this simply - their plan is to build a platform that allows its customers to program cells as easily as they do with computers. The platform will be distributed to all relevant sectors - agriculture, medicine and the chemical industry. Will humanity so easily accept a future in which they own nothing but are hackable and programmable animals? Some definitely want to live it and run to get vaccinated while fighting over